Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

Hyde, C., Wake, B., Bryan, S., Barton, P. M., Fry-Smith, A., Davenport, C. and Song, F. (2002) Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technology Assessment, 6 (2). pp. 1-89. ISSN 2046-4924

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Centres > Population Health
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:10
Last Modified:	20 Jun 2024 11:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/12946
DOI:	10.3310/hta6020

Actions (login required)

View Item